Inclacumab, which Pfizer obtained in its 2022 acquisition of Global Blood Therapeutics, failed to significantly lower pain ...

Pfizer set about evaluating inclacumab in pair of phase 3 studies, dubbed Thrive. The Big Pharma terminated one of those ...

In the latest setback for Pfizer's sickle cell anemia treatments, experimental drug inclacumab failed to meet the main goal ...

Net Loss: BioXcel Therapeutics an operating loss of $15.9 million and a net loss of $19.2 million for the second quarter of 2025, compared to an operating loss of $17.3 million and net loss of $8.3 ...

DUBLIN, Aug. 1, 2025 /PRNewswire/ -- Mallinckrodt plc and Endo, Inc. today announced that they have completed their merger to create a global, scaled, diversified therapeutics leader. "We are ...

MILPITAS, Calif., July 30, 2025 /PRNewswire/ -- Galaxy Therapeutics, a privately held, clinical-stage medical device company focused on treating brain aneurysms, today announced the official ...

Doveris’ suspense-driven tale of female empowerment is one of the most prominent titles at August’s Sanfic Industria’s WIP Iberoamericano.

The gun used in the massacre was seen smeared with blood. Obtained by the NY Post Photos show the green handguard of the rifle soaked in blood on the carpet in a 33rd-floor office inside 345 Park ...

Shaquille O’Neal’s longstanding feud with Timberwolves center Rudy Gobert took an even more drastic twist.

Scientists across the world are developing artificial blood that can last for years and be used in emergency situations ...

EXCLUSIVE: Sony Pictures Television has sold Outlander: Blood of My Blood across major markets across EMEA, LATAM, and APAC. SPT has finalized licensing agreements with MGM+ (U.K.), Deutsche ...